Key takeaways:
Acamprosate is a first-choice medication for treating alcohol use disorder. It reduces alcohol cravings and may also improve alcohol withdrawal symptoms.
Acamprosate takes about 5 days to start working. Taking it consistently will help you get the most benefits.
If you return to drinking alcohol while taking acamprosate, talk to your treatment team. But keep taking acamprosate — alcohol and acamprosate aren’t known to interact negatively.
Acamprosate tablets are available as a low-cost generic. You can save up to 80% off the average retail price of acamprosate tablets at certain pharmacies with a free GoodRx discount.
Acamprosate is a prescription medication that treats alcohol use disorder (AUD). It works primarily by decreasing alcohol cravings. It can be a vital medication for people who take it. So if you or a loved one is prescribed acamprosate, knowing a few facts about it can help you get the most from it.
Here, we’ll answer some frequently asked questions about acamprosate, including how long it takes to work and what happens if you drink alcohol while taking it.
Acamprosate takes about 5 days to start working. This means that you’ll need to take your doses regularly for at least 5 days before you start getting the full benefits. After these initial days, you’ll need to take acamprosate consistently to continue benefiting from it.
How long acamprosate takes to work is different from the amount of time it takes acamprosate to be absorbed. Your body absorbs each acamprosate dose in just a few hours. But it takes about 5 days for acamprosate to reach steady levels in your blood and significantly decrease your alcohol cravings.
Long-term alcohol use changes the balance of certain chemicals in the brain, including gamma-aminobutyric acid (GABA) and glutamate. It’s not clear how acamprosate works, but it might be by mimicking GABA. This lowers glutamate levels.
People with AUD have higher glutamate levels in the brain. High glutamate levels reinforce the desire to drink and can worsen alcohol withdrawal symptoms. So by decreasing glutamate, acamprosate can reduce cravings for alcohol. It may also help with alcohol withdrawal symptoms.
It depends on many factors, such as how severe your AUD is and what your goals are. There’s not an exact length of treatment that's right for everyone.
That said, some experts believe that you should take acamprosate at least 6 months. This may increase your chances of maintaining sobriety. And in some cases, your prescriber may recommend you take it for longer. Although long-term acamprosate use (greater than one year) hasn’t been well studied, it appears to be well-tolerated in most people.
If you start drinking alcohol again while taking acamprosate, you can continue taking acamprosate. Alcohol and acamprosate don’t cause a negative interaction in your body. But contact your prescriber about what to do next.
Relapse is often a part of the recovery process. It doesn’t mean you failed your treatment. Your healthcare team can talk with you about how to avoid triggers and strengthen your recovery program if you’ve relapsed.
Besides acamprosate, two other medications are FDA approved for AUD: naltrexone (Vivitrol) and disulfiram.
Naltrexone and acamprosate are considered first-choice medications for AUD. Disulfiram is a “second-choice” medication, which means it’s usually only used if naltrexone or acamprosate doesn’t work, or if they can’t be used.
Acamprosate, naltrexone, and disulfiram all work in different ways and can cause different side effects. They’re also taken differently. For example, oral naltrexone and disulfiram are usually only taken once a day, while acamprosate is taken three times a day. There’s also an injectable version of naltrexone that’s administered once a month in your prescriber’s office. Acamprosate and disulfiram are only available as oral tablets.
If you have certain health conditions, one medication may be better for you than another. For example, if you have severe liver damage, acamprosate may be a better option for you than naltrexone.
Acamprosate is safe for most people, though side effects are possible. The most common side effects include nausea, diarrhea, and gas. Trouble sleeping and mood changes are also possible.
More seriously, depression and suicidal thoughts and behaviors have been associated with acamprosate. However, people with AUD have a higher risk of these symptoms in general. You may also be more likely to have mood changes if you start drinking alcohol again while taking acamprosate.
If you notice mood changes after starting acamprosate or at any other point during treatment, contact your healthcare team. Along with your family and friends, they can help support you if you relapse to drinking alcohol.
If you or someone you know is having thoughts of suicide, you’re not alone, and help is available. Call the National Suicide Prevention Lifeline at 988, or text HOME to 741-741 to reach the Crisis Text Line.
Acamprosate is available as a lower-cost generic. You can save up to 80% off the average retail price at certain pharmacies with a free GoodRx discount. With the discount, generic acamprosate’s price may be as low as $67.82.
Acamprosate is a commonly used medication for alcohol use disorder. It works by balancing the levels of certain chemicals in your brain, which minimizes alcohol cravings and may also improve alcohol withdrawal symptoms.
Acamprosate takes about 5 days to start working. How long you’ll need to take it depends on your individual situation, but many experts recommend taking it for at least 6 months.
Acamprosate’s most common side effects are nausea, diarrhea, and gas. Rarely, it can also cause mood changes, including depression and suicidal thoughts and actions.
If you relapse to drinking alcohol while taking acamprosate, you can continue taking it. But let your prescriber know immediately so they can help you with next steps in the recovery process.
American Psychiatric Association. (2018). Practice guideline for the pharmacological treatment of patients with alcohol use disorder.
Banerjee, N. (2014). Neurotransmitters in alcoholism: A review of neurobiological and genetic studies. Indian Journal of Human Genetics.
Canadian Agency for Drugs and Technologies in Health. (2015). Appendix 4: Guidelines and recommendations. Long-term use of acamprosate calcium for alcoholism: A review of the clinical effectiveness, safety, and guidelines.
Dharavath, R. N., et al. (2023). GABAergic signaling in alcohol use disorder and withdrawal: Pathological involvement and therapeutic potential. Frontiers in Neural Circuits.
Kampman, K. M., et al. (2009). Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence. Addictive Behaviors.
Mason, B. J., et al. (2010). Acamprosate: A prototypic neuromodulator in the treatment of alcohol dependence. CNS & Neurological Disorders Drug Targets.
Rizk, M. M., et al. (2021). Suicide risk and addiction: The impact of alcohol and opioid use disorders. Current Addiction Reports.
Substance Abuse and Mental Health Services Administration. (2015). Medication for the treatment of alcohol use disorder: A brief guide. U.S. Department of Health and Human Services.
Zydus Pharmaceuticals (USA) Inc. (2023). Acamprosate calcium- acamprosate calcium tablet, delayed release [package insert].
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.